Vanessa is a sought-after and highly accomplished trial lawyer and strategist who achieves successful results in high-stakes business and IP litigations for clients in the technology, life sciences, pharmaceutical, and chemical sectors. Her practice encompasses complex patent litigations and disputes, Hatch-Waxman and biosimilar matters, IPRs, licensing controversies and arbitrations, strategic IP assessment, and IP counseling.

As a skilled litigator who has never lost a trial on behalf of her clients, Vanessa handles patent trials before US district courts, the US Court of Appeals for the Federal Circuit, and the Patent Trial and Appeal Board. She has also been counsel of record when submitting amicus briefs to the Supreme Court of the United States on behalf of world-leading academic research institutions.

With significant experience and success representing clients for their blockbuster products with multibillion dollars in sales, Vanessa's cases have spanned technologies in a wide range of areas, including cancer treatments, gene therapies, HIV/AIDS, cosmetic and dermatologic conditions, FemTech (technologies for women's health), prostate disorders, molecular cloning, musculoskeletal disorders, autoimmune and neurological disorders, Wi-Fi photo frames, and printing technology.

Vanessa works with Fortune 500 and 1000 companies, start-ups, and world-leading academic research institutions, including Bristol Myers Squibb, GSK, Servier Pharmaceuticals, GW Pharmaceuticals, Jazz Pharmaceuticals, Alexion Pharmaceuticals, Sword Health, Sunovion Pharmaceuticals, Galderma, AstraZeneca, Gilead Sciences, Novartis, Shire LLC (now Takeda Pharmaceutical Company), Supernus Pharmaceuticals, UCB, Celltech (now part of USB), Eisai Co., Canon USA, Netgear, St. Jude's Children's Hospital, Albert Einstein College of Medicine, University of Texas MD Anderson Cancer Center, Temple Health, Fred Hutchinson Cancer Center, and Wisconsin Alumni Research Foundation (WARF).

Vanessa has been named a "Top 100 Women Leader of New York" by Women We Admire and a "US Rising Star in Intellectual Property" by LMG Life Sciences. IAM Patent 1000 identified Vanessa as a leading practitioner and lauded her "exceptional skill sets and profound insights into patent matters" while "maintaining clear strategic vision."  The Financial Times commended one of Vanessa's cases as a "Top Litigation Dispute" of 2019, and LMG Life Sciences named the successful result of another of her cases as "The Hatch-Waxman Impact Case of the Year" in 2019.

Prior to joining Mintz, Vanessa was a partner in the Intellectual Property, Patent, Trademark and Copyright Litigation group at a global law firm. Vanessa also co-chaired the firm’s Asian Affinity Diversity Committee.

Vanessa graduated from MIT and Cornell Law. Prior to law, Vanessa conducted years of breast cancer research at Cold Spring Harbor Laboratories and worked on the Human Genome Project at MIT. At MIT, she was admitted to the Sigma Xi honor society.